AU2003237076A1 - Therapeutical use of anti-cd70 antibody for treating or preventing aids - Google Patents
Therapeutical use of anti-cd70 antibody for treating or preventing aidsInfo
- Publication number
- AU2003237076A1 AU2003237076A1 AU2003237076A AU2003237076A AU2003237076A1 AU 2003237076 A1 AU2003237076 A1 AU 2003237076A1 AU 2003237076 A AU2003237076 A AU 2003237076A AU 2003237076 A AU2003237076 A AU 2003237076A AU 2003237076 A1 AU2003237076 A1 AU 2003237076A1
- Authority
- AU
- Australia
- Prior art keywords
- antibody
- treating
- therapeutical use
- preventing aids
- aids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL2003/000385 WO2004104045A1 (en) | 2003-05-23 | 2003-05-23 | Therapeutical use of anti-cd70 antibody for treating or preventing aids |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003237076A1 true AU2003237076A1 (en) | 2004-12-13 |
Family
ID=33476091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003237076A Abandoned AU2003237076A1 (en) | 2003-05-23 | 2003-05-23 | Therapeutical use of anti-cd70 antibody for treating or preventing aids |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003237076A1 (en) |
WO (1) | WO2004104045A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080025989A1 (en) | 2003-02-20 | 2008-01-31 | Seattle Genetics, Inc. | Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
JP5356648B2 (en) | 2003-02-20 | 2013-12-04 | シアトル ジェネティックス, インコーポレイテッド | Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
AU2005295595C1 (en) | 2004-10-15 | 2012-06-21 | Seattle Genetics, Inc. | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders |
US8337838B2 (en) | 2004-10-15 | 2012-12-25 | Seattle Genetics, Inc. | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders |
EP1934261B1 (en) | 2005-09-26 | 2014-10-29 | Medarex, L.L.C. | Human monoclonal antibodies to cd70 |
JP2016531920A (en) | 2013-09-05 | 2016-10-13 | アデュロ・バイオテック・ホールディングス・ヨーロッパ・ベスローテン・フエンノートシャップAduro Biotech Holdings, Europe B.V. | CD70 binding peptides and related methods, processes and uses |
CN116490210A (en) * | 2020-11-23 | 2023-07-25 | 山东先声生物制药有限公司 | CD70 antibody and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6312700B1 (en) * | 1998-02-24 | 2001-11-06 | Andrew D. Weinberg | Method for enhancing an antigen specific immune response with OX-40L |
-
2003
- 2003-05-23 AU AU2003237076A patent/AU2003237076A1/en not_active Abandoned
- 2003-05-23 WO PCT/NL2003/000385 patent/WO2004104045A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004104045A1 (en) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173386A0 (en) | Use of adcc-optimized antibodies for treating weak patients | |
AU2003224788A1 (en) | Method for treatment of tissue | |
AU2004255187A1 (en) | Device for treatment of human or animal barrier membranes | |
AU2003298043A1 (en) | Surface treatment of medical device | |
AU2003249244A1 (en) | Methods for the treatment of neoplasms | |
AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
AU2002257936A1 (en) | Methods of well treatment | |
DE60322451D1 (en) | 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
IL175412A0 (en) | Use of specific histones for the treatment of parasitic diseases | |
AU2003260778A1 (en) | Treatment of pipes | |
AU2003237076A1 (en) | Therapeutical use of anti-cd70 antibody for treating or preventing aids | |
AU2003223538A1 (en) | Methods for the treatment of cancer | |
AU2003249930A1 (en) | Proteaseome inhibitors for the treatment of herpesviridae infected individuals | |
AU2003277728A1 (en) | Apparatus for the biological treatment of wastewater | |
EP1691776A4 (en) | Treatment of aids | |
AU2003221005A1 (en) | Method of wastewater treatment | |
AU2004281077A1 (en) | Methods and agents for the treatment of cancer | |
AU2002249891A1 (en) | Compounds and methods for the diagnosis and treatment of babesia infection | |
AU2001281465A1 (en) | Treatment of rosacea | |
AU2002951913A0 (en) | Method of treatment | |
AU2003274359A1 (en) | Treatment of fluids | |
AU2002342715A1 (en) | Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors | |
AU2002343085A1 (en) | Tnf-alpha inhibitors for the treatment of hepatic diseases | |
AU2003208809A1 (en) | Treatment of neuroblastoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |